41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Witnesses
- Louise Dubé, Principal(Office of the Auditor General of Canada)
- Paul Glover, Assistant Deputy Minister, Health Products and Food Branch (HPFB)(Health Canada)
- Neil Maxwell, Assistant Auditor General(Office of the Auditor General of Canada)
- Barbara Sabourin, Director General, Therapeutic Products Directorate, HPFB(Health Canada)
- Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, TPD(Health Canada)
Meeting with interpretation and transcription